, ,
Presentations this author is a contributor to:
Progression free survival vs overall survival: An example from randomised phase III trial with Axitinib (AXIS) in metastatic renal cell carcinoma (#721)
3:00 PM
Mahmood Alam
COSA Posters: Clinical Research
A personalised approach to treating cancer; a cross-sectional review to understand public perception and its capacity to influence clinical outcomes (#722)
3:00 PM
Mahmood Alam
COSA Posters: Clinical Research